ATI RN
ATI Pharmacology Assessment 1 II Questions
Question 1 of 5
A nurse is providing teaching to a client who has type 2 diabetes mellitus and is starting to take immediate-release exenatide. Which of the following client statements indicates an understanding of the teaching?
Correct Answer: D
Rationale: The correct answer is D: "I will take this medication one hour before morning and evening meals." This statement indicates understanding of the teaching because immediate-release exenatide should be taken 1 hour before the two main meals of the day to optimize its effectiveness in controlling blood sugar levels. Taking it at this specific timing helps synchronize the peak action of the medication with the rise in blood sugar after the meals.
Explanation of Why Other
Choices are Incorrect:
A: Discarding the open injector pen after two months is incorrect as the pen should be discarded 30 days after first use for hygiene and safety reasons.
B: Injecting the medication into the muscle of the thigh is incorrect as exenatide is typically injected subcutaneously, not into the muscle.
C: Storing open injector pens at room temperature is incorrect as they should be refrigerated to maintain stability and potency.
E, F, G: Not applicable as the correct answer has been identified.
Question 2 of 5
A nurse is teaching a client who has a new prescription for benzonatate. Which of the following statements by the client indicates an understanding of the teaching?
Correct Answer: A
Rationale: The correct answer is A: "I should not drive while taking this medication." Benzonatate is a cough suppressant that can cause drowsiness and dizziness. Driving while taking this medication can impair the client's ability to operate a vehicle safely. This statement demonstrates an understanding of the potential side effects of benzonatate.
Choice B is incorrect because benzonatate is not an expectorant that helps with mucus clearance.
Choice C is incorrect as there is no need to decrease dietary fiber intake while taking benzonatate.
Choice D is incorrect because benzonatate should not be chewed as it may cause numbing of the mouth and throat.
Question 3 of 5
A nurse is caring for a client who has hyperlipidemia and a prescription for colesevelam. The nurse should monitor the client for which of the following manifestations as an adverse effect of colesevelam?
Correct Answer: D
Rationale: The correct answer is D: Constipation. Colesevelam is a bile acid sequestrant used to lower cholesterol levels. It can cause constipation as a common side effect due to its mechanism of action in binding bile acids in the intestines. This can lead to reduced intestinal motility and fecal bulk. Hyperglycemia (
A) is not a common adverse effect of colesevelam. Stomatitis (
B) refers to inflammation of the mouth and is not associated with colesevelam. Fever (
C) is not a typical side effect of this medication.
Therefore, option D is the correct answer.
Question 4 of 5
A nurse is reviewing the health history of a client who experiences migraine headaches and has asked about a prescription for sumatriptan. Which of the following conditions should the nurse identify as a contraindication for taking sumatriptan?
Correct Answer: D
Rationale: The correct answer is D: Coronary artery disease. Sumatriptan is a vasoconstrictor and can constrict coronary arteries, potentially leading to chest pain or heart attack in individuals with coronary artery disease. This contraindication is due to the increased risk of cardiovascular events. Asthma (choice
A), kidney disease (choice
B), and rheumatoid arthritis (choice
C) are not contraindications for taking sumatriptan. Asthma is not directly affected by sumatriptan, kidney disease does not have a direct interaction with sumatriptan, and rheumatoid arthritis is not a contraindication for sumatriptan use.
Question 5 of 5
A nurse is caring for a group of clients. The nurse should monitor which of the following clients for manifestations of hypokalemia?
Correct Answer: A,B,E
Rationale: The correct answer is A, B, and E. Hypokalemia is a condition characterized by low potassium levels in the blood. Clients taking prednisone (
A), torsemide (
B), and hydrochlorothiazide (E) are at risk for developing hypokalemia due to the diuretic effects of these medications, which can lead to potassium loss through urine. Monitoring these clients for manifestations of hypokalemia, such as muscle weakness, fatigue, and cardiac dysrhythmias, is essential.
Choices C and D are incorrect because polystyrene sulfonate is used to treat hyperkalemia, and spironolactone is a potassium-sparing diuretic that can lead to hyperkalemia.